Authors: Mortimore, M Gibson, PR Selby, WS Radford-Smith, GL Florin, THJ

Citation: M. Mortimore et al., Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy?, INTERN M J, 31(3), 2001, pp. 146-150

Authors: Michael-Robinson, JM Reid, LE Purdie, DM Biemer-Huttmann, AE Walsh, MD Pandeya, N Simms, LA Young, JP Leggett, BA Jass, JR Radford-Smith, GL

Citation: Jm. Michael-robinson et al., Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer, CLIN CANC R, 7(8), 2001, pp. 2347-2356

Authors: Michael-Robinson, JM Biemer-Huttmann, AE Purdie, DM Walsh, MD Simms, LA Biden, KG Young, JP Leggett, BA Jass, JR Radford-Smith, GL

Citation: Jm. Michael-robinson et al., Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status, GUT, 48(3), 2001, pp. 360-366

Authors: Radford-Smith, GL Taylor, P Florin, THJ

Citation: Gl. Radford-smith et al., Mycophenolate mofetil in IBD patients, LANCET, 354(9187), 1999, pp. 1386-1387